Cocrystal Pharma Files 8-K with Bylaw Amendments
Ticker: COCP · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1412486
| Field | Detail |
|---|---|
| Company | Cocrystal Pharma, INC. (COCP) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
TL;DR
Cocrystal Pharma filed an 8-K on 6/18/25 for bylaw changes and financials.
AI Summary
Cocrystal Pharma, Inc. filed an 8-K on June 18, 2025, reporting amendments to its Articles of Incorporation or Bylaws and filing financial statements and exhibits. The report covers events as of June 17, 2025. The company, formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc., is incorporated in Delaware and headquartered in Bothell, WA.
Why It Matters
This filing indicates corporate governance updates and the submission of financial information, which are crucial for investors to assess the company's operational and legal standing.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative or positive news.
Key Players & Entities
- Cocrystal Pharma, Inc. (company) — Registrant
- BIOZONE PHARMACEUTICALS, INC. (company) — Former company name
- International Surf Resorts, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Bothell, WA (location) — Principal executive offices
- June 17, 2025 (date) — Date of earliest event reported
- June 18, 2025 (date) — Filing date
FAQ
What specific amendments were made to Cocrystal Pharma's Articles of Incorporation or Bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the provided text excerpt.
What financial statements and exhibits are being filed with this 8-K?
The filing states that financial statements and exhibits are being filed, but the specific list or content is not detailed in the excerpt.
When was the earliest event reported in this 8-K?
The earliest event reported in this 8-K was on June 17, 2025.
What is Cocrystal Pharma, Inc.'s principal executive office address?
Cocrystal Pharma, Inc.'s principal executive office is located at 19805 N. Creek Parkway, Bothell, WA 98011.
What were Cocrystal Pharma's previous company names?
Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Cocrystal Pharma, Inc. (COCP).